1. Genenta Science SpA - ADR
  2. Company Profile
person reading

About Genenta Science SpA - ADR - Company Information, Overview, History and Profile

What does Genenta Science SpA - ADR do?

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Genenta Science SpA - ADR Management structure

All Gross Remunerations are in USD
Mr. Richard B. Slansky
Chief Financial Officer
-
2022
Gross Remuneration
Year
Mr. Pierluigi Paracchi
Chief Executive Officer, Vice Chairman of the Board and General Manager
-
2022
Gross Remuneration
Year
Dr. Carlo Russo, M.D.
Chief Medical Officer and Head of Development
-
2022
Gross Remuneration
Year
Dr. Stefania Mazzoleni, PhD
Scientific Project Manager and Communications Officer
-
2022
Gross Remuneration
Year
Ms. Barbara Regonini
Finance Director
-
2022
Gross Remuneration
Year

Genenta Science SpA - ADR Board of directors

All Gross Remunerations are in USD
Mr. Anthony S. Marucci
Independent Director
-
2022
Gross Remuneration
Year
Dr. Mark A. Sirgo, PhD
Chairman of the Board
-
2022
Gross Remuneration
Year
Dr. Stephen P. Squinto, PhD
Independent Director
-
2022
Gross Remuneration
Year
Mr. Roger Abravanel
Independent Director
-
2022
Gross Remuneration
Year
Mr. Guido Angelo Giovanni Guidi
Independent Director
-
2022
Gross Remuneration
Year
Mr. Pierluigi Paracchi
Chief Executive Officer, Vice Chairman of the Boar
-
2022
Gross Remuneration
Year